Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PRLHR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CALML4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
IL34 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDS5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLAIN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MLH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RORA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100287210 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
CRP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XPNPEP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFYA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLK15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRCH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STRN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX19A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on